Skip to Main Content

Paper Details

DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma.
Nat Med
156
2017
Developmental tumors, EWS, Ewing sarcoma, Ewing sarcoma tumors, FLI1, cancer, cancers, children, enhancers, patients, stem cell, tumor, tumors
Adolescent, Adult, Bone Neoplasms, Cell Line, Tumor, Child, Child, Preschool, DNA Methylation, Epigenesis, Genetic, Female, Gene Expression Regulation, Neoplastic, Genetic Heterogeneity, Humans, Male, Middle Aged, Oncogene Proteins, Fusion, Promoter Regions, Genetic, Proto-Oncogene Protein c-fli-1, RNA-Binding Protein EWS, Sarcoma, Ewing, Young Adult
Author NameAffiliation
Nathan Sheffield (CM4AI)CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Ga??lle PierronInstitut Curie, PSL Research University
Johanna KlughammerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Paul DatlingerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Andreas Sch??neggerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Michael SchusterCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Johanna HadlerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Didier SurdezInstitut Curie, PSL Research University, INSERM
Delphine GuillemotInstitut Curie, PSL Research University
Eve LapoubleInstitut Curie, PSL Research University
Paul Fr??neauxInstitut Curie, PSL Research University
Jacqueline ChampigneulleHopitaux de Brabois
Raymonde BouvierHopitaux de Lyon
Diana WalderChildren's Cancer Research Institute
Inge M AmbrosChildren's Cancer Research Institute
Caroline HutterSt. Anna Children's Hospital
Caroline HutterMedical University of Vienna
Eva SorzChildren's Cancer Research Institute
Ana Teresa AmaralInstitute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla
Enrique de AlavaInstitute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla
Katharina SchallmoserParacelsus Medical University
Katharina SchallmoserParacelsus Medical University
Dirk StrunkParacelsus Medical University
Dirk StrunkInstitute for Experimental and Clinical Cell Therapy, Paracelsus Medical University
Beate RinnerMedical University of Graz
Bernadette Liegl-AtzwangerInstitute of Pathology, Medical University of Graz
Berthold HuppertzMedical University of Graz
Andreas LeithnerMedical University of Graz
Gonzague de PinieuxHopital Universitaire Trousseau
Philippe Terrier
Val??rie LaurenceInstitut Curie, PSL Research University
Val??rie LaurenceInstitut Curie, PSL Research University
Jean MichonInstitut Curie, PSL Research University
Ruth LadensteinChildren's Cancer Research Institute
Ruth LadensteinSt. Anna Children's Hospital
Ruth LadensteinMedical University of Vienna
Wolfgang HolterChildren's Cancer Research Institute
Wolfgang HolterSt. Anna Children's Hospital
Wolfgang HolterMedical University of Vienna
Reinhard WindhagerVienna General Hospital, Medical University of Vienna
Uta DirksenUniversity Hospital Munster
Uta DirksenUniversity Hospital Munster
Peter F AmbrosChildren's Cancer Research Institute
Peter F AmbrosMedical University of Vienna
Olivier DelattreInstitut Curie, PSL Research University
Olivier DelattreInstitut Curie, PSL Research University, INSERM
Heinrich KovarChildren's Cancer Research Institute
Heinrich KovarMedical University of Vienna
Heinrich KovarChildren's Cancer Research Institute
Heinrich KovarMedical University of Vienna
  • 1 - 50

Datasets